Home/Filings/4/0001787306-23-000064
4//SEC Filing

LIN SUE-JEAN 4

Accession 0001787306-23-000064

CIK 0001787306other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 7:22 PM ET

Size

7.0 KB

Accession

0001787306-23-000064

Insider Transaction Report

Form 4
Period: 2023-05-31
LIN SUE-JEAN
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-31+12,22012,220 total
    Exercise: $7.51Exp: 2033-05-31Common Stock (12,220 underlying)
  • Award

    Common Stock

    2023-05-31+4,3758,987 total
Footnotes (2)
  • [F1]Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
  • [F2]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001867788

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:22 PM ET
Size
7.0 KB